Asgard Therapeutics is a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy. The company builds on ground-breaking and proprietary reprogramming technologies to develop gene therapy products designed to set in motion efficient and personalized immune responses. Backed by top investors, Asgard Therapeutics aims to establish a pipeline of off-the shelf cancer immunotherapies that trigger personalized anti-cancer immune responses for the benefit of cancer patients in need.
Company Details
- Employees
- 27
- Founded
- -
- Address
- Lund, Sköna 221 84, Se
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- asgardthx.com
- HQ
- Lund, Sköna
Asgard Therapeutics Questions
Asgard Therapeutics's website is asgardthx.com
Asgard Therapeutics's LinkedIn profile is https://se.linkedin.com/company/asgardthx
Asgard Therapeutics has
27 employees.
View email and phone details for 27
employees at Asgard Therapeutics.
Asgard Therapeutics's industry is
Biotechnology Research
Asgard Therapeutics's top competitors are
Cellcolabs,
Lund Stem Cell Center,
Bioarctic,
Northx Biologics,
Bioinvent International Ab,
Alligator Bioscience Ab,
Anocca,
Nextcell Pharma Ab,
Atmp Sweden,
Biolamina.
Asgard Therapeutics's categories are Biotechnology Research
Asgard Therapeutics's founding year is 2018
